Article: Axikin and Proteros Enter into Fragment-Based Lead Discovery Collaboration.

SAN DIEGO, Calif. & MUNICH, Germany -- Axikin Pharmaceuticals ("Axikin"), San Diego, CA, U.S.A. and Proteros fragments ("Proteros"), Munich, Germany, a specialist structure-based lead discovery company, are pleased to announce today that they have entered into a significant research service collaboration to discover novel, customized lead compounds for the treatment of inflammatory diseases.

Under the terms of this collaboration, Proteros will provide multi-disciplinary research teams with the aim of generating multiple advanced lead series inhibiting a novel proprietary target protein.

In the initial stages of the programme Proteros shall solve the ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!